A novel loop-structure-based bispecific CAR that targets CD19 and CD22 with enhanced therapeutic efficacy against B-cell malignances.
Zhao L, Li S, Wei X, Qi X, Guo Q, Shi L, Zhang JS, Li J, Liu ZL, Guo Z, Zhang H, Feng J, Shi Y, Zhang S, Cao YJ.
Zhao L, et al. Among authors: guo q.
Protein Cell. 2024 Jun 1:pwae034. doi: 10.1093/procel/pwae034. Online ahead of print.
Protein Cell. 2024.
PMID: 38823002
Free article.
No abstract available.